• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Providers

Latest News

Based on the model, over 3 million MACE were projected over the following 10 years, approximately 496,000 of which could be prevented with the use of semaglutide. | Image credit: peter hansen - stock.adobe.com
Semaglutide Use Could Prevent Up to 2 Million MACE in 10 Years, Model Suggests

April 9th 2025

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

AJMC
Organizational Factors Associated With Variation in Primary Care Providers in ACOs

April 8th 2025

AJMC
Coverage With Evidence Development Study Shows Benefits in Patients With Migraine Treated With Remote Electrical Neuromodulation

April 8th 2025

ACC.25
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

April 4th 2025

Patient at cardiologist visit | Image credit: Chinnapong – stock.adobe.com
Three New Studies Explore Treatment Strategies for Heart Failure and Comorbid Conditions

April 4th 2025

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.